# Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)

> **NCT00358527** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 401 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Mometasone Furoate Nasal Spray (MFNS)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00358527
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-10
- **Final completion:** 2006-11
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2022-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358527, "Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00358527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
